Objective: To investigate the knowledge of university students regarding pandemic and seasonal influenza.
Design: Online questionnaire-based survey of undergraduate and postgraduate students, including those on nursing, medical, other health and non-health related courses.
Method: The sample was recruited using the university email system, and the survey was administered using SurveyMonkey. The questionnaire sought the following data: demographics; general knowledge; intentions with regards to vaccines, pharmacological and behavioural interventions; personal susceptibility and the symptoms of influenza; and the provision of information.
Results: Approximately half (56 per cent) of respondents were on health-related courses. There was a good level of knowledge about influenza and its severity, and the importance of vaccination, although few intended actually receiving the seasonal or pandemic vaccines (23 per cent and 21 per cent respectively). However, in the event of a pandemic most students would still attend college (60 per cent) and almost half would still attend social events (47 per cent). Many thought that there had been hype by the government (44 per cent) and the media (89 per cent).
Conclusions: There was a good level of knowledge about influenza, although this was not always reflected in intended behaviours with regards to vaccination and isolation.
FergusonNMGalvaniAPBushRM. Ecological and immunological determinants of influenza evolution. Nature, 2003: 422: 428–433.
2.
CarratFFlahaultA. Influenza vaccine: The challenge of antigenic drift. Vaccine, 2007: 25(39–40): 6852–6862.
3.
World Health Organization. Human infection with new influenza A (H1N1) virus: Mexico, update, March–May 2009. Weekly Epidemiological Record, 2009: 84: 213–236, 5June.
Department for Education and Skills. Infection Control – How to Reduce the Spread of Pandemic Flu: Guidance for Further Education Colleges and Higher Education Institutions. London: Department for Education and Skills, 2007.
8.
AndersonRM. Infectious Diseases of Humans. Oxford: Oxford University Press, 1991.
9.
SalgadoCDFarrBMHallKKHaydenFG. Influenza in the acute hospital setting. The Lancet Infectious Diseases, 2002: 2(3): 145–155.
10.
FismanDNSavageRGubbayJ. Older age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med, 2009: 361(20): 2000–2001.
11.
WallingaJTeunisPKretzschmarM. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol, 2006: 164(10): 936–944.
WhiteLFWallingaJFinelliL. Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza and Other Respiratory Viruses, 2009: 3(6): 267–276.
14.
LipsitchMRileySCauchemezSGhaniACFergusonNM. Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med, 2009: 361(2): 112–115.
15.
WallingaJvan BovenMLipsitchM. Optimizing infectious disease interventions during an emerging epidemic. Proceedings of the National Academy of Sciences, 2010: 107(2): 923–928.
16.
EdmundsWJKafatosGWallingaJMossongJR. Mixing patterns and the spread of close-contact infectious diseases. Emerging Themes in Epidemiology, 2006: 3(10): DOI:10.1186/1742-7622-3-10.
17.
MossongJHensNJitM. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Medicine, 2008: 5: 381–391.
18.
BernardHFischerRMikolajczykRTKretzschmarMWildnerM. Nurses’ contacts and potential for infectious disease transmission. Emerging Infectious Diseases, 2009: 15(9): 1438–1444.
19.
NicholKL. Heterogeneity of influenza case definitions and implications for interpreting and comparing study results. Vaccine, 2006: 24(44–46): 6726–6728.
20.
Chief Medical Officer. Pandemic H1N1 (2009) influenza. Chief Medical Officer’s Fortnightly Bulletin for Journalists Issue 2, Thursday 4 February 2010. London: Department of Health, 2010.
21.
Caban-MartinezAJLeeDJDavilaEP. Sustained low vaccination rates in US healthcare workers. Preventative Medicine, 2010: 50: 210–212.
22.
SmedleyJPooleJWaclawskiE. Influenza immunisation: attitudes and beliefs of UK healthcare workers. Occupational and Environmental Medicine, 2007: 64(4): 223–227.
23.
HeiningerU. A risk-benefit analysis of vaccination. Vaccine, 2009: 27(Supplement 6): G9–G12.
24.
HollmeyerHGHaydenFPolandGBuchholzU. Influenza vaccination of health care workers in hospitals – A review of studies on attitudes and predictors. Vaccine, 2009: 27(30): 3935–3944.
25.
EllisCMcEwenR. Who should receive Tamiflu for swine flu?BMJ, 2009: 339: b2698.
26.
National Institute of Health and Clinical Excellence. Amantadine, Oseltamivir and Zanamivir for the Treatment of Influenza (Review of Existing Guidance No. 58). London: National Institute of Health and Clinical Excellence, 2009.
27.
BurchJCorbettMStockC. Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. The Lancet Infectious Diseases, 2009: 9(9): 537–545.
28.
WeberTPStilianakisNI: Inactivation of influenza A viruses in the environment and modes of transmission: A critical review. Journal of Infection, 2008: 57: 361–373.
